Fund Holdings — RA CAPITAL MANAGEMENT, L.P.

Total Portfolio Value:
$9.76B
Total Bought:
$1.25B
Total Sold:
$1.04B
Net Transaction:
+$214.87M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ascendis Pharma A/SSH(ASND)10,281,49610,281,4960$2.04B$2.19B22.46%+$148.36M
Cidara Therapeutics IncSH3,365,5233,365,5230$322.28M$743.41M7.62%+$421.13M
Rhythm Pharmaceuticals, Inc.SH(RYTM)5,681,3596,666,837+985,478$573.76M$713.62M7.31%+$139.86M
Avidity Biosciences IncSH8,641,0318,641,0310$376.49M$623.28M6.39%+$246.79M
Vaxcyte, Inc.SH(PCVX)11,965,99110,724,599-1,241,392$431.01M$494.83M5.07%+$63.82M
Sionna Therapeutics, Inc.SH(SION)10,445,3229,905,045-540,277$307.20M$407.49M4.17%+$100.30M
Newamsterdam Pharma Co NvSH
ORDINARY SHARES
10,138,9389,550,191-588,747$288.35M$335.02M3.43%+$46.67M
Tyra Biosciences, Inc.SH(TYRA)12,198,62512,198,6250$170.66M$320.70M3.29%+$150.04M
Wave Life Sciences, Inc.SH(WVE)18,202,00918,203,009+1,000$133.24M$309.45M3.17%+$176.21M
Mineralys Therapeutics, Inc.SH(MLYS)7,323,7507,323,7500$277.72M$265.78M2.72%-$11.94M
Edgewise Therapeutics, Inc.SH(EWTX)10,428,43710,428,4370$169.15M$258.78M2.65%+$89.63M
Septerna, Inc.SH(SEPN)6,995,8586,995,8580$131.59M$195.04M2.00%+$63.45M
Nuvalent Inc-ASH1,246,4561,880,057+633,601$107.79M$189.11M1.94%+$81.32M
Disc Medicine, Inc.SH(IRON)1,577,1061,976,132+399,026$104.22M$156.92M1.61%+$52.71M
Janux Therapeutics, Inc.SH(JANX)11,189,69311,189,6930$273.48M$154.42M1.58%-$119.06M
PepGen Inc.SH(PEPG)20,064,54520,064,5450$92.70M$130.62M1.34%+$37.92M
Taysha Gene Therapies, Inc.SH(TSHA)23,555,64823,555,6480$77.03M$129.56M1.33%+$52.53M
ARS Pharmaceuticals, Inc.SH(SPRY)10,860,97710,860,9770$109.15M$126.53M1.30%+$17.38M
BioCryst Pharmaceuticals, Inc.SH(BCRX)015,827,186+15,827,186$0$123.45M1.26%+$123.45M
Bicara Therapeutics IncSH6,955,9936,955,9930$109.84M$117.07M1.20%+$7.23M
Praxis Precision Medicines, Inc.SH(PRAX)0373,787+373,787$0$110.17M1.13%+$110.17M
GH Research PLCSH(GHRS)7,676,6977,676,6970$109.78M$97.49M1.00%-$12.28M
Geron CorporationSH(GERN)60,379,36663,771,366+3,392,000$82.72M$84.18M0.86%+$1.46M
Arcellx IncSH
COMMON STOCK
3,036,5271,267,156-1,769,371$249.30M$82.62M0.85%-$166.68M
Climb Bio, Inc.SH(CLYM)31,419,26711,293,828-20,125,439$63.15M$77.71M0.80%+$14.56M
Vor Biopharma Inc.SH(VOR)1,982,3015,404,998+3,422,697$96.58M$70.70M0.72%-$25.88M
Belite Bio, IncSH(BLTE)875,000432,484-442,516$64.75M$69.18M0.71%+$4.43M
Fulcrum Therapeutics, Inc.SH(FULC)10,229,0996,053,960-4,175,139$94.11M$68.47M0.70%-$25.64M
LENZ Therapeutics, Inc.SH(LENZ)4,178,8234,178,8230$194.65M$66.86M0.68%-$127.79M
Dianthus Therapeutics, Inc.SH(DNTH)2,866,7331,611,733-1,255,000$112.81M$66.42M0.68%-$46.39M
Olema Pharmaceuticals, Inc.SH(OLMA)02,600,000+2,600,000$0$65.00M0.67%+$65.00M
Evommune, Inc.SH(EVMN)03,458,770+3,458,770$0$59.21M0.61%+$59.21M
Jade Biosciences IncSH1,062,3263,671,083+2,608,757$9.17M$56.64M0.58%+$47.48M
Spyre Therapeutics, Inc.SH(SYRE)01,621,620+1,621,620$0$53.12M0.54%+$53.12M
Lexeo Therapeutics, Inc.SH(LXEO)05,000,000+5,000,000$0$49.65M0.51%+$49.65M
LB Pharmaceuticals IncSH(LBRX)1,776,9582,208,604+431,646$28.06M$49.16M0.50%+$21.11M
Monopar Therapeutics Inc.SH(MNPR)511,207667,207+156,000$41.75M$43.57M0.45%+$1.82M
Capricor Therapeutics, Inc.SH(CAPR)01,507,844+1,507,844$0$43.52M0.45%+$43.52M
4d Molecular Therapeutics InSH4,563,2115,653,211+1,090,000$39.65M$42.40M0.43%+$2.74M
Invivyd, Inc.SH(IVVD)17,119,09617,119,0960$18.83M$42.28M0.43%+$23.45M
Artiva Biotherapeutics, Inc.SH(ARTV)9,853,3029,853,3020$28.28M$42.27M0.43%+$13.99M
GRAIL, Inc.SH(GRAL)0428,266+428,266$0$36.66M0.38%+$36.66M
Assembly Biosciences IncSH1,020,4101,020,4100$26.12M$34.70M0.36%+$8.58M
Solid Biosciences IncSH5,811,4235,811,4230$35.86M$32.78M0.34%-$3.08M
Acumen Pharmaceuticals, Inc.SH(ABOS)14,932,06314,932,0630$25.53M$31.51M0.32%+$5.97M
Benitec Biopharma Inc.SH(BNTC)01,850,000+1,850,000$0$24.92M0.26%+$24.92M
Contineum Therapeutics, Inc.SH(CTNM)2,122,0002,179,711+57,711$24.93M$24.91M0.26%-$19.4K
Rezolute, Inc.SH(RZLT)09,180,000+9,180,000$0$21.66M0.22%+$21.66M
Acrivon Therapeutics IncSH8,340,5088,340,5080$15.10M$20.10M0.21%+$5.00M
Nkarta, Inc.SH(NKTX)10,805,12910,805,1290$22.37M$19.99M0.20%-$2.38M
Ovid Therapeutics Inc.SH(OVID)010,714,000+10,714,000$0$17.46M0.18%+$17.46M
Palisade Bio, Inc.SH(PALI)07,124,116+7,124,116$0$16.74M0.17%+$16.74M
SAB Biotherapeutics, Inc.SH(SABS)4,401,5004,401,5000$8.85M$16.46M0.17%+$7.61M
C4 Therapeutics, Inc.SH(CCCC)08,000,000+8,000,000$0$15.28M0.16%+$15.28M
Medline Inc.SH(MDLN)0335,000+335,000$0$14.07M0.14%+$14.07M
Design Therapeutics, Inc.SH(DSGN)475,6991,461,381+985,682$3.58M$13.71M0.14%+$10.13M
Inspire Medical Systems, Inc.SH(INSP)114,901141,964+27,063$8.53M$13.09M0.13%+$4.57M
Avalo Therapeutics, Inc.SH(AVTX)662,968662,9680$8.43M$12.04M0.12%+$3.61M
Rani Therapeutics Holdings, Inc.SH(RANI)08,500,000+8,500,000$0$11.47M0.12%+$11.47M
Perceptive Capital SolutionsSH
CL A ORD SHS
750,000750,0000$7.95M$9.77M0.10%+$1.82M
Adicet Bio IncSH0948,249+948,249$0$7.98M0.08%+$7.98M
Newamsterdam Pharma Co Nv-27SH
*W EXP 99/99/999
333,333333,3330$5.70M$7.67M0.08%+$1.96M
GeneDx Holdings Corp.SH(WGS)58,04458,0440$6.25M$7.55M0.08%+$1.30M
Waystar Holding Corp.SH(WAY)0144,400+144,400$0$4.73M0.05%+$4.73M
Werewolf Therapeutics, Inc.SH(HOWL)6,681,3076,681,3070$13.16M$4.23M0.04%-$8.93M
Hinge Health, Inc.SH(HNGE)080,113+80,113$0$3.72M0.04%+$3.72M
Progyny IncSH96,62896,6280$2.08M$2.48M0.03%+$402.0K
Qiagen N.V.SH(QGEN)043,976+43,976$0$2.08M0.02%+$2.08M
OrthoPediatrics Corp.SH(KIDS)0109,959+109,959$0$1.95M0.02%+$1.95M
Health Catalyst, Inc.SH(HCAT)0793,749+793,749$0$1.90M0.02%+$1.90M
Palatin Technologies, Inc.SH(PTN)070,000+70,000$0$1.08M0.01%+$1.08M
Adicet Bio IncSH7,541,0000-7,541,000$6.11M$0—-$6.11M
89bio IncSH19,889,6830-19,889,683$292.38M$0—-$292.38M
Arcus Biosciences, Inc.SH(RCUS)1,136,3640-1,136,364$15.45M$0—-$15.45M
CytomX Therapeutics, Inc.SH(CTMX)2,661,3310-2,661,331$8.49M$0—-$8.49M
Eledon Pharmaceuticals, Inc.SH(ELDN)3,566,3380-3,566,338$9.24M$0—-$9.24M
Larimar Therapeutics, Inc.SH(LRMR)6,045,3510-6,045,351$19.53M$0—-$19.53M
Metsera IncSH675,5250-675,525$35.35M$0—-$35.35M
Scholar Rock Holding CorporationSH(SRRK)1,166,7880-1,166,788$43.45M$0—-$43.45M
Structure Therapeutics IncSH1,517,4180-1,517,418$42.49M$0—-$42.49M
Surrozen, Inc.SH(SRZN)602,6260-602,626$7.76M$0—-$7.76M
Tango Therapeutics, Inc.SH(TNGX)2,000,0000-2,000,000$16.80M$0—-$16.80M
Travere Therapeutics, Inc.SH(TVTX)1,150,0000-1,150,000$27.48M$0—-$27.48M
InflaRx N.V.SH(IFRX)1,973,2330-1,973,233$2.64M$0—-$2.64M
Prime Medicine, Inc.SH(PRME)3,000,0000-3,000,000$16.62M$0—-$16.62M
Evolent Health, Inc.SH(EVH)579,0520-579,052$4.90M$0—-$4.90M
Endeavour Silver Corp.SH(EXK)54,9390-54,939$3.01M$0—-$3.01M
Glaukos CorporationSH(GKOS)54,1800-54,180$4.42M$0—-$4.42M
uniQure N.V.SH(QURE)200,0000-200,000$11.67M$0—-$11.67M
Page 1 of 1
RA CAPITAL MANAGEMENT, L.P. — 13F Holdings — Q4 2025 | TickerTrail